Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2026-01-20 @ 3:29 PM
Study NCT ID:
NCT04656418
Status:
COMPLETED
Last Update Posted:
2023-06-29
First Post:
2020-12-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks
Sponsor:
CSL Behring
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CSL312_3001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None